Relief Therapeutics Holding AG (RLFTF)

[tcm55]

The USA is the Major market when dispensing starts, we have most of the sick. 10 employees with only 1 CRO guy starting in Sept as CMO and 1 at SA Board. Nrx also top heavy too, IMO. Development/cost$/logistics(?) of RLF-100 IV will be handled by RLF. I dont see where/how RLF fits into the new scheme of NRX/NYSE Bio co.
All eggs in the 102 patient review and not even talk of completing the first part of the IV 2B Trial, and nothing on amount of patients needed to reach statistical significance with the Phase 3 part. Seeing the last FDA update on approvals seems to show Full Data is King/Queen/Game or dont apply, IMO. Huge amount of 'Hope' for FDA EUA, general approvals on the 102. Guess Dr JJ/NRX feels no need for further plans. Kept pushing the 21 data.
EOD volume at SIX/here ? anyone have an opinion besides me. Price after this news.